SG
Sagimet Biosciences Inc.
SGMT · NASDAQ
$10.80 -3.10% (-$0.34)
1M +8.62%
Market Cap $351.9M
P/E Ratio -
Div. Yield -
ROE 31.96%
Bulios Fair Price
$8.28
23.3% downside
Trenutna cena
$10.8
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SGMT trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 1.37x
EV/EBITDA N/A
P/S N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 31.96%
ROA 17.87%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 45.02x
Debt/Equity 0.01x
Net debt/EBITDA N/A
Stability
44 /100
Moderate EPS volatility 8.80%
Profitable years 0
Beta 3.49x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SGMT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David Happel
Employees
16
Headquarters
San Mateo
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report